Clinical Trials Directory

Trials / Conditions / Esophagogastric Junction Adenocarcinoma

Esophagogastric Junction Adenocarcinoma

9 registered clinical trials studyying Esophagogastric Junction Adenocarcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for R
NCT07059299
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 1
RecruitingSintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06761846
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
RecruitingEfficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroes
NCT06461910
Zekuan XuPhase 2
RecruitingPerioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab
NCT06482788
Ruijin HospitalPhase 2
RecruitingNeoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
NCT05170503
Sun Yat-sen UniversityPhase 2
WithdrawnStudy of FMT Combined With Nivolumab in Gastric Cancer
NCT05001360
Fujian Cancer HospitalN/A
UnknownClinical Outcomes of Robotic Versus Laparoscopic Assisted Radical Gastrectomy for Advanced Siewert II/III AEG
NCT04153058
Fujian Medical UniversityN/A
UnknownA Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewer
NCT04423354
Guangdong Provincial Hospital of Traditional Chinese MedicineN/A
CompletedAMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
NCT00719550
AmgenPhase 1 / Phase 2